Fields »
ABOUT
HELP
BLOG

116 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 3 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
MMP26Matrix metallopeptidase 26
Tissue enriched64endometrium:23.8
IGFBP1Insulin-like growth factor binding protein 1
Golgi apparatusRenal cancer: 6.90e-11
Lung cancer: 1.03e-4
Stomach cancer: 6.64e-4
Group enriched53endometrium:120.4
liver:562.2
placenta:264.8
MMP10Matrix metallopeptidase 10N/A
Plasma membrane
Cytosol		Urothelial cancer: 7.12e-4
Tissue enriched39endometrium:443.1
TEX15Testis expressed 15
Nuclear specklesGroup enriched31endometrium:10.9
smooth muscle:8.2
testis:22.2
ADAMTS19ADAM metallopeptidase with thrombospondin type 1 motif, 19N/A
Vesicles
Midbody		Group enriched13cervix, uterine:16.4
endometrium:16.4
placenta:5.2
smooth muscle:8.9
GPR22G protein-coupled receptor 22
Group enriched13adrenal gland:2.4
cerebral cortex:9.5
cervix, uterine:6.3
endometrium:5.0
heart muscle:11.9
CHRDL2Chordin-like 2
MitochondriaUrothelial cancer: 6.08e-4
Group enriched9appendix:162.3
endometrium:128.0
gallbladder:169.0
smooth muscle:181.2
urinary bladder:45.0
MMP11Matrix metallopeptidase 11
Renal cancer: 2.62e-4
Group enriched9cervix, uterine:30.9
endometrium:122.3
placenta:27.9
TRHThyrotropin-releasing hormone
Group enriched9cervix, uterine:31.9
endometrium:27.4
ESR1Estrogen receptor 1
Nucleus
Vesicles		Endometrial cancer: 5.47e-7
Group enriched8breast:37.4
cervix, uterine:127.3
endometrium:179.7
fallopian tube:105.5
smooth muscle:75.9
PRLProlactin
CytosolGroup enriched8endometrium:10.7
placenta:27.1
ZCCHC12Zinc finger, CCHC domain containing 12
Nuclear bodiesThyroid cancer: 3.42e-5
Group enriched8endometrium:165.7
fallopian tube:182.3
smooth muscle:201.4
PAEPProgestagen-associated endometrial protein
Renal cancer: 0.00e+0
Liver cancer: 6.61e-6
Stomach cancer: 5.46e-4
Tissue enriched7endometrium:437.4
PRLHRProlactin releasing hormone receptor
Group enriched7adrenal gland:6.5
cerebral cortex:3.5
endometrium:3.9
smooth muscle:5.4
PTGER3Prostaglandin E receptor 3 (subtype EP3)
Renal cancer: 3.50e-4
Group enriched7adipose tissue:58.5
endometrium:114.7
kidney:87.6
smooth muscle:103.9
AGTR2Angiotensin II receptor, type 2
Group enriched6cervix, uterine:6.8
endometrium:13.8
fallopian tube:3.8
lung:12.6
smooth muscle:17.4
ANO4Anoctamin 4N/A
Renal cancer: 5.48e-5
Group enriched6adrenal gland:17.6
cerebral cortex:10.0
cervix, uterine:12.5
endometrium:8.3
ovary:10.9
prostate:10.9
seminal vesicle:11.3
ASIC2Acid sensing (proton gated) ion channel 2
Group enriched6cerebral cortex:8.7
cervix, uterine:3.9
endometrium:6.4
smooth muscle:2.1
CDC20BCell division cycle 20B
Group enriched6endometrium:1.2
fallopian tube:3.4
kidney:1.2
testis:4.7
IGFN1Immunoglobulin-like and fibronectin type III domain containing 1
Midbody ringRenal cancer: 1.27e-8
Group enriched6endometrium:17.1
epididymis:18.1
skeletal muscle:60.2
IHHIndian hedgehog
Endometrial cancer: 3.67e-6
Group enriched6cervix, uterine:8.8
colon:21.4
duodenum:15.3
endometrium:31.4
rectum:16.9
small intestine:16.8
stomach:15.6
IL17CInterleukin 17C
Tissue enriched6endometrium:3.5
LEFTY2Left-right determination factor 2
Group enriched6endometrium:270.5
smooth muscle:56.3
MSX1Msh homeobox 1
NucleoplasmEndometrial cancer: 1.64e-7
Renal cancer: 1.18e-5
Group enriched6cervix, uterine:60.9
endometrium:23.8
PGRProgesterone receptor
Endometrial cancer: 5.76e-8
Group enriched6cervix, uterine:95.8
endometrium:171.3
fallopian tube:52.8
smooth muscle:113.5
SLC46A2Solute carrier family 46, member 2
Group enriched6cervix, uterine:23.0
endometrium:5.5
epididymis:5.4
lung:15.2
skin:11.3
WNT2Wingless-type MMTV integration site family member 2
VesiclesGroup enriched6endometrium:23.6
placenta:92.5
EMX2Empty spiracles homeobox 2
NucleusRenal cancer: 2.28e-13
Cervical cancer: 2.80e-4
Group enriched5cervix, uterine:59.4
endometrium:114.7
epididymis:113.9
fallopian tube:72.9
kidney:38.3
seminal vesicle:64.9
smooth muscle:59.6
SFRP4Secreted frizzled-related protein 4
Renal cancer: 1.36e-5
Group enriched5cervix, uterine:931.0
endometrium:772.5
fallopian tube:335.6
TMEM215Transmembrane protein 215N/A
Group enriched5cervix, uterine:1.0
endometrium:4.8
testis:4.2
thyroid gland:1.8
AC066615.1N/A
Tissue enhancedendometrium:2.1
urinary bladder:1.7
AC074033.1
Tissue enhancedendometrium:2.0
ADAMTS7ADAM metallopeptidase with thrombospondin type 1 motif, 7N/A
VesiclesStomach cancer: 9.53e-4
Tissue enhancedendometrium:7.2
ADAMTSL1ADAMTS-like 1
Tissue enhancedendometrium:20.7
ADRA2CAdrenoceptor alpha 2CN/A
Tissue enhancedcervix, uterine:21.0
endometrium:26.0
seminal vesicle:26.7
ALDH1A2Aldehyde dehydrogenase 1 family, member A2
Tissue enhancedendometrium:117.2
fallopian tube:107.1
AP000349.2
Tissue enhancedcervix, uterine:2.2
endometrium:4.0
ASPNAsporin
Nucleoplasm
Vesicles		Renal cancer: 1.64e-7
Tissue enhancedendometrium:114.7
smooth muscle:159.0
BNC2Basonuclin 2
Nucleus
Cytosol		Tissue enhancedendometrium:44.4
ovary:39.3
smooth muscle:47.3
C1QTNF6C1q and tumor necrosis factor related protein 6
NucleusRenal cancer: 0.00e+0
Lung cancer: 9.60e-6
Tissue enhancedendometrium:52.2
placenta:41.1
CDH13Cadherin 13
Plasma membraneRenal cancer: 1.73e-6
Tissue enhancedendometrium:82.5
CEMIPCell migration inducing protein, hyaluronan binding
Urothelial cancer: 2.65e-4
Tissue enhancedendometrium:54.5
CPXM1Carboxypeptidase X (M14 family), member 1
Renal cancer: 4.62e-10
Tissue enhancedendometrium:130.2
gallbladder:132.9
CTC-273B12.7
Tissue enhancedcolon:1.2
endometrium:1.3
testis:2.8
CYP24A1Cytochrome P450, family 24, subfamily A, polypeptide 1
Nucleoplasm
Plasma membrane
Mitochondria		Tissue enhancedendometrium:24.8
urinary bladder:52.7
DLX5Distal-less homeobox 5
NucleusTissue enhancedendometrium:20.1
placenta:13.5
skin:17.2
DLX6Distal-less homeobox 6N/A
Nuclear bodiesTissue enhancedendometrium:4.4
placenta:4.3
testis:5.4
DPP6Dipeptidyl-peptidase 6
Tissue enhancedcerebral cortex:51.2
endometrium:27.4
EPOErythropoietin
Renal cancer: 2.18e-6
Liver cancer: 5.67e-5
Tissue enhancedcervix, uterine:2.0
endometrium:1.7
liver:1.7
FAPFibroblast activation protein, alpha
Head and neck cancer: 4.82e-4
Tissue enhancedendometrium:50.4

Page of 3 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.